PITTSBURGH, Feb. 5, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will announce its fourth quarter and full-year 2023 financial results Wednesday, Feb. 28, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results. Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for inter ...

Maca and Naca/E+ via Getty Images Viatris Inc. (NASDAQ:VTRS) is an American pharmaceutical company formed as a result of the merger of Mylan and Upjohn. The company is one of the leaders in the generics industry. Thesis Over the past two and a half months, Viatris' share price has risen more than 38%, reflecting increasing sales of its branded drugs in recent quarters, stock market euphoria about the expected Fed interest-rate cuts in 2024, and statements from its management, which anticipates the company t ...

JP Morgan Healthcare Conference January 10, 2024 Forward Looking Statements This presentation contains "forward-looking statements". These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include, without limitation, statements about: Viatris successfully reshaping the Company by delivering on Phase 1 commitments, Viatris has significant financial flexibility and multiple levers to drive future growth, Via ...

Viatris Inc. (NASDAQ:VTRS) J.P. Morgan 42nd Annual Healthcare Conference January 10, 2024 1:30 PM ET Company Participants Scott A. Smith - CEO Rajiv Malik - President Sanjeev Narula - CFO Conference Call Participants Chris Schott - J.P. Morgan Chris Schott Good morning, everybody. I'm Chris Schott at J.P. Morgan. And it's my pleasure to be hosting a fireside chat today with Viatris. From the company, we're going to have a quick presentation from CEO, Scott Smith and we're going to open up to a Q&A session w ...

Viatris Inc. (NASDAQ:VTRS) J.P. Morgan 42nd Annual Healthcare Conference January 10, 2024 1:30 PM ET Company Participants Scott A. Smith - CEO Rajiv Malik - President Sanjeev Narula - CFO Conference Call Participants Chris Schott - J.P. Morgan Chris Schott Good morning, everybody. I'm Chris Schott at J.P. Morgan. And it's my pleasure to be hosting a fireside chat today with Viatris. From the company, we're going to have a quick presentation from CEO, Scott Smith and we're going to open up to a Q&A session w ...

1 This document contains proprietary information of Viatris Inc. Unauthorized use, duplication, dissemination or disclosure to third parties is strictly prohibited. © 2023 Viatris Inc. All Rights Reserved. VIATRIS and the Viatris Logo are trademarks of Mylan Inc., a Viatris company. Q3 2023 Earnings November 7, 2023 Forward Looking Statements This presentation contains "forward-looking statements". These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform A ...

Company Participants Scott Smith - Chief Executive Officer Sanjeev Narula - Chief Financial Officer Conference Call Participants Nathan Rich - Goldman Sachs Glenn Santangelo - Jefferies Ash Verma - UBS Operator I will now turn the call over to Bill Szablewski, Head of Global Capital Markets. Please go ahead, sir. Please refer to today's slide presentation and our SEC filings for a fuller explanation of those risks and uncertainties. We will also be referring to certain actual and projected non-GAAP financia ...

Form 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from _____________to___________ Commission file number 001-39695 VIATRIS INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incor ...

William Szablewski - Head of Global Capital Markets Viatris Inc. (NASDAQ:VTRS) Q2 2023 Earnings Call Transcript August 7, 2023 8:30 AM ET Scott Smith - Chief Executive Officer Conference Call Participants Jason Gerberry - Bank of America David Amsellem - Piper Sandler Operator William Szablewski We will be referring to certain actual and projected non-GAAP financial measures to supplement investors' understanding and assessment of our financial performance. Reconciliations of those non-GAAP measures to the ...

Forward Looking Statements Non-GAAP Financial Measures and Other Information Divestiture adjusted operational change refers to operational changes, further adjusted for the impact of the biosimilars divestiture in November 2022 by excluding biosimilars net sales from 2022 periods, and a reclassification to conform prior year amounts to current year presentation of divestiture adjusted operational net sales. SG&A and R&D TSA Reimbursement 3 This document contains proprietary information of Viatris Inc. Unaut ...